Donna Steel
Adult Health · Wynnewood, PANPI 1982670527
Payments from drug & device makers
Across 1,097 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$3K
- Novo Nordisk$3K
- Amgen$2K
- Cequr Corporation$2K
- Sanofi-aventis U.S. LLC$2K
- Boehringer Ingelheim$1K
- plus $10K from 34 others
What the payments were for
- Speaking & faculty fees$2,1339%
- Food & beverage$21,16889%
- Education$1751%
- Gifts$2381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 152 | $3,111 |
| Novo Nordisk | 195 | $2,965 |
| Amgen | 121 | $2,356 |
| Cequr Corporation | 6 | $1,815 |
| Sanofi-aventis U.S. LLC | 60 | $1,688 |
| Boehringer Ingelheim | 62 | $1,396 |
| Abbott | 67 | $1,396 |
| AstraZeneca(2 entities) | 76 | $1,350 |
| Dexcom, Inc. | 35 | $871 |
| Tandem Diabetes Care, Inc. | 37 | $846 |
| Medtronic | 24 | $650 |
| Xeris Pharmaceuticals, Inc. | 37 | $632 |
| Merck | 26 | $581 |
| Bayer | 35 | $580 |
| Mannkind Corporation | 17 | $567 |
| AbbVie | 27 | $449 |
| Averitas Pharma Inc. | 16 | $376 |
| Amarin Pharma, Inc. | 24 | $358 |
| Amphastar Pharmaceuticals, Inc. | 9 | $191 |
| Insulet Corporation | 8 | $175 |
| IBSA Pharma Inc. | 8 | $156 |
| Ascendis Pharma Endocrinology Inc | 2 | $147 |
| Novartis | 6 | $127 |
| Ascensia Diabetes Care US Inc. | 5 | $118 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $100 |
| GRT US Holding, Inc. | 4 | $79 |
| Radius Health, Inc. | 2 | $75 |
| BD | 4 | $75 |
| BETA Bionics, Inc. | 3 | $65 |
| Amneal Pharmaceuticals LLC | 4 | $59 |
| Lifescan, Inc. | 3 | $57 |
| Corcept Therapeutics | 3 | $50 |
| Sequel Med Tech, LLC | 2 | $44 |
| Hologic Sales And Service, LLC | 3 | $42 |
| Bigfoot Biomedical Inc | 2 | $40 |
| Embecta Corp. | 2 | $39 |
| Kyowa Kirin, Inc. | 2 | $36 |
| Nevro Corp. | 1 | $19 |
| Theracosbio, LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$1,688
- SOLIQUA 100/33$375
- MINIMED 780G$263
- EVENITY$233
- FREESTYLE LIBRE 3$147
- Ozempic$125
- TEPEZZA$125
- JARDIANCE$124
- Yorvipath$122
- t:slim X2 Insulin Pump with Control-IQ$114
- DEXCOM G6 TRANSMITTER$107
How this compares
$23,713 in reported general payments places this provider in the 95th percentile of 899 adult health providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 748 | $1,166,932 |
| JardianceEmpagliflozin | 859 | $1,008,394 |
| MounjaroTirzepatide | 652 | $810,013 |
| FarxigaDapagliflozin Propanediol | 218 | $202,014 |
| TrulicityDulaglutide | 123 | $196,358 |
| JanuviaSitagliptin Phosphate | 156 | $168,334 |
| Tresiba Flextouch U-200Insulin Degludec | 180 | $151,904 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 85 | $100,230 |
| GlyxambiEmpagliflozin/Linagliptin | 92 | $98,872 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 111 | $80,803 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 54 | $58,962 |
| Novolog FlexpenInsulin Aspart | 206 | $52,862 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 23 | $47,773 |
| Tresiba Flextouch U-100Insulin Degludec | 77 | $45,549 |
| RybelsusSemaglutide | 22 | $40,796 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Xultophy 100-3.6, Rybelsus, Fiasp, Novolog | $2,965 | $1,300,220833 claims |
| Boehringer IngelheimJardiance, Glyxambi, Tradjenta, Synjardy Xr, Jentadueto | $1,396 | $1,181,9571,013 claims |
| Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog | $3,111 | $1,034,190815 claims |
| MerckJanuvia, Janumet Xr, Janumet | $581 | $286,907256 claims |
| AstraZenecaFarxiga | $1,350 | $202,014218 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCCycloset | $100 | $22,25813 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $1,688 | $18,37518 claims |
| AbbVieSynthroid | $449 | $13,393124 claims |
| Cequr CorporationCequr Simplicity | $1,815 | $12,36613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 899 adult health providers in Pennsylvania.
Other adult health in Wynnewood
- Beth SandyPhiladelphia$924K
- Diane NewmanPhiladelphia$413K
- Jennifer MondilloSchwenksville$396K
- Elizabeth FaustDouglassville$356K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Lauren MassimoPhiladelphia$139K
- Jennifer KeeleyWexford$97K
- Debra EvansFarrell$85K
- Bethann MallonBlue Bell$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.